logo

For the Inventor, By the Inventor

Takarazuka, Japan

Kaoru Kikuchi

This inventor holds 8 USPTO granted patents and 1 EPO patent. Top assignees: Dainippon Sumitomo Pharma Co., Ltd., Sumitomo Pharmaceuticals Company Limited, Japan Science and Technology Agency. Active years: 1999-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kaoru Kikuchi. Retrieved from https://idiyas.com/inventor/kaoru-kikuchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 62.5


Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Takarazuka, JP (1999 - 2008)
  • Hyogo, JP (2003 - 2008)

Company Filing History:

goldMedal4 out of 140 
 
Dainippon Sumitomo Pharma Co., Ltd.
 patents
silverMedal4 out of 174 
 
Sumitomo Pharmaceuticals Company Limited
 patents
bronzeMedal1 out of 1,328 
 
Japan Science and Technology Agency
 patents
where one patent can have more than one assignee

Years Active: 1999-2008

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 7407766 - Screening method for agonists or antagonists of semaphorin 6C by determining the effect of a test compound on the interaction between semaphorin 6C and plexin-A1 (2008-08-05),
2. 7317038 - Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient (2008-01-08),
3. 7273922 - Semaphorin Z and gene encoding the same (2007-09-25),
4. 7244761 - Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient (2007-07-17),
5. 6902730 - Semaphorin gene: Semaphorin W (2005-06-07),
6. 6576441 - Semaphorin Z and gene encoding the same (2003-06-10),
7. 6566094 - Semaphorin gene: Semaphorin Y (2003-05-20),
8. 5939534 - Factors mutated in the D1 cap region (1999-08-17),

Title: Kaoru Kikuchi: Innovator in Nerve Regeneration

Introduction

Kaoru Kikuchi is a prominent inventor based in Takarazuka, Japan. He has made significant contributions to the field of nerve regeneration, holding a total of 8 patents. His work focuses on developing innovative methods and compounds that promote nerve healing and regeneration.

Latest Patents

Kikuchi's latest patents include a screening method for agonists or antagonists of semaphorin 6C. This method determines the effect of a test compound on the interaction between semaphorin 6C and plexin-A1. The invention provides tools for screening and evaluates the connectivity of proteins involved in nerve regeneration. Another notable patent involves nerve regeneration promoters containing semaphorin inhibitors as active ingredients. This invention aims to provide remedies for neuropathic and neurodegenerative diseases by utilizing low-molecular weight compounds that inhibit semaphorin activity.

Career Highlights

Throughout his career, Kaoru Kikuchi has worked with notable companies such as Dainippon Sumitomo Pharma Co., Ltd. and Sumitomo Pharmaceuticals Company Limited. His experience in these organizations has contributed to his expertise in the pharmaceutical and biotechnology sectors.

Collaborations

Kikuchi has collaborated with esteemed colleagues, including Toru Kimura and Kazuo Kumagai. These partnerships have enhanced his research and development efforts in the field of nerve regeneration.

Conclusion

Kaoru Kikuchi's innovative work in nerve regeneration and his numerous patents highlight his significant impact on medical science. His contributions continue to pave the way for advancements in treatments for nerve-related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…